Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
39.11B | 36.10B | 34.54B | 31.40B | 31.67B | 33.33B | Gross Profit |
8.71B | 7.72B | 7.06B | 6.77B | 6.60B | 6.52B | EBIT |
1.47B | 882.77M | 548.46M | 559.51M | 778.10M | 399.63M | EBITDA |
2.17B | 1.99B | 1.58B | 1.83B | 242.25M | 1.34B | Net Income Common Stockholders |
1.06B | 779.85M | 331.34M | 750.84M | -847.08M | 268.36M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.67B | 8.48B | 8.26B | 7.56B | 6.49B | 4.66B | Total Assets |
28.00B | 28.36B | 27.20B | 27.05B | 24.89B | 23.84B | Total Debt |
4.06B | 4.98B | 5.13B | 3.82B | 3.33B | 2.47B | Net Debt |
-3.61B | -3.50B | -3.12B | -3.74B | -3.16B | -2.07B | Total Liabilities |
12.39B | 13.14B | 13.00B | 13.22B | 11.36B | 9.84B | Stockholders Equity |
15.61B | 15.22B | 14.20B | 13.82B | 13.53B | 14.00B |
Cash Flow | Free Cash Flow | ||||
0.00 | 924.34M | -502.24M | 345.68M | 1.30B | -706.18M | Operating Cash Flow |
0.00 | 1.68B | 790.45M | 1.75B | 2.51B | 1.11B | Investing Cash Flow |
0.00 | -1.20B | -1.21B | -889.09M | -1.31B | -1.76B | Financing Cash Flow |
0.00 | -253.79M | 1.16B | 310.62M | 607.72M | 399.54M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $6.10T | 30.97 | 20.56% | 0.83% | 13.56% | 12.76% | |
77 Outperform | ¥5.43B | 5.27 | 2.37% | 10.40% | 60.55% | ||
77 Outperform | $17.43T | 28.90 | 10.50% | 1.03% | 0.56% | 5.32% | |
70 Outperform | ¥4.35T | 25.68 | 3.37% | 9.08% | -33.61% | ||
70 Outperform | $3.78T | 10.17 | 7.85% | 3.07% | 1.72% | -33.60% | |
66 Neutral | $766.46B | 48.32 | 2.10% | 2.64% | -6.57% | -76.15% | |
64 Neutral | $4.43B | 12.01 | 5.15% | 249.50% | 3.98% | -11.60% |